Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study-Reference-Cited by-同舟云学术

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study

Published:2023-11 Issue:11 Volume:10 Page:e902-e912
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Pabst Thomas,Papayannidis Cristina,Demirkan Fatih,Doronin Vadim,Fogliatto Laura M,Guttke Christina,Gyan Emmanuel,Hamad Nada,Herrera Pilar,Hultberg Anna,Jacobs Julie,Johnson Amy J,Langlois Angélique,Ma Xuewen,Martinelli Giovanni,Arnan Montserrat,Müller Rouven,Nottage Kerri,Ofran Yishai,Özcan Muhit,Samoilova Olga,Tolbert Jaszianne A,Trudel Géralyn C,Xiu Liang,Vey Norbert,Wei Andrew H

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Hematology

Reference22 articles.

1. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Ley;N Engl J Med,2013

2. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Heuser;Ann Oncol,2020

3. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older;Prassek;Haematologica,2018

4. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: results of EUROCARE-5 population-based study;De Angelis;Eur J Cancer,2015

5. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display for discovery of anticancer antibodies;New Biotechnology;2024-11

2. Targeting CD70 in acute myeloid leukaemia: an emerging therapeutic angle in combinatorial treatment;The Lancet Haematology;2023-11